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BACKGROUND/OBJECTIVE: It is expected that dairy products such as cheeses, which are the main source of cholesterol and 
saturated fat, may lead to the development or increase the risk of cardiovascular and metabolic diseases; however, the results 
of different studies are inconsistent. This study was conducted to assess the association between cheese consumption and 
cardiovascular risk factors in an Iranian adult population.
SUBJECTS/METHODS: Information from the Isfahan Healthy Heart Program (IHHP) was used for this cross-sectional study with 
a total of 1,752 participants (782 men and 970 women). Weight, height, waist and hip circumference measurement, as well 
as fasting blood samples were gathered and biochemical assessments were done. To evaluate the dietary intakes of participants 
a validated food frequency questionnaire, consists of 49 items, was completed by expert technicians. Consumption of cheese 
was classified as less than 7 times per week and 7-14 times per week. 
RESULTS: Higher consumption of cheese was associated with higher C-Reactive Protein (CRP), apolipoprotein A and high density 
lipoprotein cholesterol (HDL-C) level but not with fasting blood sugar (FBS), total cholesterol, low density lipoprotein cholesterol 
(LDL-C), triglyceride (TG) and apolipoprotein B. Higher consumption of cheese was positively associated with consumption 
of liquid and solid oil, grain, pulses, fruit, vegetable, meat and dairy, and negatively associated with Global Dietary Index. 
After control for other potential confounders the association between cheese intake and metabolic syndrome (OR: 0.81; 96%CI: 
0.71-0.94), low HDL-C level (OR: 0.87; 96%CI: 0.79-0.96) and dyslipidemia (OR: 0.88; 96%CI: 0.79-0.98) became negatively significant. 
CONCLUSION: This study found an inverse association between the frequency of cheese intake and cardiovascular risk factors; 
however, further prospective studies are required to confirm the present results and to illustrate its mechanisms.
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INTRODUCTION15)
Despite the progresses in health care, cardiovascular disease 
(CVD) remains the main cause of death worldwide [1]. Recently 
cardiovascular mortality is increasing in developing countries, 
mostly because of the influence of Western lifestyle, such as 
smoking, lack of physical activity and dietary habits. In Iran, as 
a developing country, CVDs are considered as the most leading 
causes of mortality [2] and there is a rising trend in its 
prevalence [3]. CVD occurred as a result of numerous risk factors 
such as, diabetes, obesity, high blood pressure, dyslipidemia 
and smoking [4]. Furthermore, dietary factors and life style 
patterns are more important in development of CVD [5]. Several 
investigations described the role of diet and nutrients in the 
expansion of metabolic diseases [6,7]. High intake of cholesterol 
and saturated fatty acids are associated with CVD mortality [8]. 
Despite the expectation that the dairy products (as a main 
source of cholesterol and saturated fat) may lead to develop-
ment of CVD and metabolic diseases, the results of different 
studies are inconsistent. Although several studies have shown 
the hypercholesterolaemic effect of diets rich in dairy products, 
[9,10] others couldn’t find any association between milk 
consumption and CVD [11]. Moreover, some studies showed 
positive effects on metabolic parameters as a result of consump-
tion of milk products. These studies suggest that the intake of 
dairy products, as a good source of essential nutrients and high 
quality protein, may reduce the risk of heart disease [12,13]. 
Cheese as a high saturated fat dairy product, may increase 
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cholesterol concentration and can be associated with higher 
CVD risk [14,15]; contrarily, cheese is a good source of calcium 
(Ca) that might reduce heart disease by influencing plasma lipid 
profiles [16], reduce blood pressure [17,18], and adiposity 
[19,20]. It has been claimed that the intake of fermented 
products like cheese is negatively associated with cholesterol 
concentration [21]. Previous investigations indicated that cheese 
may not have any unfavorable effect on lipid profiles [22] and 
that cheese may even have a cholesterol lowering effect [23]. 
A recent study reported that the frequency of consumption of 
cheese was negatively associated with serum TG and positively 
associated with serum HDL cholesterol [24]. In contrast, some 
studies found non-significant association between cheese 
consumption and heart disease [25,26]. Another study reported 
that cheese intake is positively associated with myocardial 
infarction [27]. Overall, due to inconsistent results, the effect 
of cheese on CVD risk factors has remained uncertain [28]. 
Cheese has been one of the most important dairy products in 
Iranian diet, especially for breakfast [29]. Furthermore, the studies 
on cheese and CVD risks were done in the western and 
developed countries with different lifestyle, and according to 
our knowledge there is no study from developing countries, 
particularly the Middle East region including Iran. Therefore, 
current study aimed to investigate the association between 




Information from the first phase of Isfahan Healthy Heart 
Program (IHHP) obtained for this cross-sectional study. Isfahan 
cardiovascular research institute and Isfahan provincial health 
office conducted the IHHP, which was a community-based 
program for cardiovascular prevention and control and healthy 
lifestyle promotion.
This study was completed in three provincial cities of Isfahan, 
Arak and Najafabad. Multistage cluster random sampling 
method was used for selecting individuals. More complete 
information about IHHP and sampling method is reported 
elsewhere [3,30]. Individuals who had dietary and anthropo-
metric data, lipid profiles, plasma glucose and other biological 
measurements were included in this study. Individuals with 
history of chronic diseases or taking medications were excluded. 
Written informed consents were obtained from all participants 
who were 1,752 people (782 men and 970 women). The Ethics 
Committee of Isfahan University of Medical approved the study.
Measurements
Trained interviewers collected demographic, socio-economic 
data, medical and family history, smoking habits, as well as 
physical activity level using pretested questionnaire. Height was 
measured in bare foot by a wall fixed measuring tape and 
weight was measured in light clothing by calibrated scale. Body 
mass index (BMI) was calculated as weight in kilogram divided 
by height in meters squared. Waist circumference at the 
smallest circumference between lowest rib and the iliac was 
horizontally measured and hip circumference measurement was 
done at the greatest point of hip.
Dietary habits
To evaluate dietary intakes of participants a validated food 
frequency questionnaire (FFQ) that consists 49 items was used 
by expert technicians. The validity of this food frequency 
questionnaire was confirmed by Medical Education Develop-
ment Center before being used [3]. The frequency and the 
portion size of consumption during the previous year for each 
food item were individually asked. Global dietary index (GDI), 
expressing diet quality, was produced by calculating the 
average of the mean of 29 frequency questions in seven 
categories.
Biochemical assessment
Blood samples were collected after overnight fasting. Fasting 
blood samples were frozen at -70℃ until being assessed at the 
central laboratory of Isfahan Cardiovascular Research Institute. 
Measurement of fasting plasma glucose (FPG), serum total 
cholesterol and TG levels was done by enzymatic colorimetric 
method. Measurement of HDL-C cholesterol was completed 
subsequent to sedimentation of non-HDL cholesterol by dextran 
sulphate-magnesium chloride. Friedewald equation [31] was 
used to calculate serum LDL-C cholesterol level. Enzyme immun-
oabsorbent and immunoassay was used to measure Apo A and 
Apo B.
Having three or more factor of FBS > 126 mg/dl or waist >
102 cm for men and > 85 cm for women or TG > 150 mg/dl 
or HLD < 40 mg/dl for men and < 50 mg/dl for women or 
systolic blood pressure > 130 mmHg and diastolic > 85 mmHg 
has been considered as metabolic syndrome. Having one 
disorder in lipid profiles (Cholesterol > 240 mg/dl, LDL-C > 160 
mg/dl, HDL-C < 40 mg/dl for men and < 50 mg/dl for women, 
TG > 200 mg/dl) has been considered as dyslipidemia.
Statistical methods
Statistical analysis was done using SPSS 15 software. Student's 
t test was applied for comparing means of continuous variables 
between categories of cheese intake. To compare categorical 
variables Chi-square test was used. Logistic regression in 
different models was used to explore the associations between 
categories of cheese consumption and cardiovascular risk 
factors. First, we adjusted for age and sex, in second model 
further adjustment was done for dietary intakes and physical 
activity and then a last adjustment was done for BMI. In all 
models cheese intake < 7 times per week was considered as 
the reference. 
RESULTS
Characteristics of study participants by frequency of cheese 
consumption per week are presented in Table 1. Individuals who 
consumed more cheese (7 ≤ times per week) were older, mostly 
female, and tended to have higher BMI, waist and waist to hip 
ratio with different education status in comparison with people 
with lower cheese intake (< 7 times per week) group. No 
significant difference was found in physical activity and smoking 
between two groups. Table 2 indicates the cardiovascular risk 
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Cheese 
P< 7 times per week
(n = 2,167)
7 ≤ times per week
(n = 7,359)
Age (yrs) 37.84 ± 15.92 39.08 ± 15.46 0.001
Males (%) 53.9 48.9 0.000
Education (%) 0.011
0-5 yrs 42.2 45.8
6-12 yrs 43.6 41.3
> 12 yrs 14.1 12.9
Physical activity (mets/day) 796.47 ± 599.01 793.93 ± 582.30 0.86
Smoking (%) 12.7 11.6 0.64
Body mass index (kg/m2) 25.32 ± 4.55 25.77 ± 4.62 0.000
Waist (cm) 88.85 ± 12.88 90.42 ± 12.71 0.000
Waist to hip ratio 0.89 ± 0.09 0.90 ± 0.09 0.000
1) Data are means ± standard deviation unless indicated.




< 7 times per week 7 ≤ times per week
Fasting blood sugar (mg/dl) 89.59 ± 25.44 88.81 ± 23.73 0.189
Total cholesterol (mg/dl) 190.88 ± 42.62 192.37 ± 41.39 0.146
HDL-c (mg/dl) 43.64 ± 10.58 44.32 ± 10.73 0.010
LDL-c (mg/dl) 117.53 ± 33.70 118.17 ± 33.74 0.446
Triglycerides (mg/dl) 151.26 ± 111.88 150.26 ± 100.02 0.709
apolipoprptein A (mg/dl) 124.35 ± 22.41 125.64 ± 23.52 0.025
apolipoprptein B (mg/dl) 97.79 ± 23.66 97.93 ± 24.34 0.821
CRP-Quantitative (mg/dl) 3.30 ± 3.05 3.60 ± 3.34 0.000
1) Data are means ± standard deviation.
HDL-c, high density lipoprotein cholesterol; LDL-c, low density lipoprotein 
cholesterol; CRP, c-reactive protein 




< 7 times per week 7 ≤ times per week
Global dietary index 0.955 ± 0.31 0.924 ± 0.32 0.000
Solid oil2) 4.86 ± 5.08 5.33 ± 5.42 0.000
Liquid oil 4.82 ± 4.53 5.33 ± 4.71 0.000
Grain 21.70 ± 7.36 23.25 ± 6.92 0.000
Pulses 2.84 ± 1.90 3.03 ± 1.98 0.000
Fruit 6.60 ± 4.81 7.32 ± 5.28 0.000
Vegetable 5.91 ± 3.65 6.27 ± 3.70 0.000
Meat 5.52 ± 2.76 6.26 ± 2.96 0.000
Dairy 8.56 ± 5.08 9.84 ± 4.94 0.000
1) Data are means ± standard deviation.
2) Dietary intakes are times per week.




< 7 times per week 7 ≤ times per week
Metabolic syndrome1)
Crude 1.00 0.97 (0.86-1.09) 0.668
Model 12) 1.00 0.88 (0.78-1.01) 0.061
Model 23) 1.00 0.88 (0.78-1.01) 0.061
Model 34) 1.00 0.81 (0.71-0.94) 0.004
Diabetes Mellitus5)
Crude 1.00 1.06 (0.87-1.28) 0.563
Model 1 1.00 1.01 (0.83-1.24) 0.893
Model 2 1.00 1.01 (0.83-1.24) 0.894
Model 3 1.00 0.99 (0.81-1.22) 0.966
Hypercholesterolemia6)
Crude 1.00 1.12 (0.97-1.30) 0.123
Model 1 1.00 1.06 (0.91-1.24) 0.445
Model 2 1.00 1.06 (0.91-1.24) 0.449
Model 3 1.00 1.05 (0.89-1.23) 0.559
High LDL -C7)
Crude 1.00 1.12 (0.96-1.32) 0.147
Model 1 1.00 1.07 (0.91-1.26) 0.430
Model 2 1.00 1.07 (0.91-1.26) 0.423
Model 3 1.00 1.06 (0.90-1.26) 0.457
Low HDL -C8)
Crude 1.00 0.92 (0.84-1.01) 0.093
Model 1 1.00 0.89 (0.80-0.98) 0.017
Model 2 1.00 0.89 (0.80-0.98) 0.019
Model 3 1.00 0.87 (0.79-0.96) 0.008
Hypertriglyceridemia9)
Crude 1.00 1.06 (0.94-1.20) 0.330
Model 1 1.00 1.05 (0.93-1.19) 0.449
Model 2 1.00 1.05 (0.93-1.19) 0.450
Model 3 1.00 1.03 (0.90-1.18) 0.637
Dyslipidemia10)
Crude 1.00 0.96 (0.87-1.07) 0.478
Model 1 1.00 0.91 (0.82-1.01) 0.069
Model 2 1.00 0.91 (0.82-1.01) 0.077
Model 3 1.00 0.88 (0.79-0.98) 0.021
High FBS level11)
Crude 1.00 0.93 (0.74-1.17) 0.539
Model 1 1.00 0.89 (0.70-1.12) 0.320
Model 2 1.00 0.89 (0.70-1.12) 0.319
Model 3 1.00 0.87 (0.68-1.11) 0.260
1) Having 3 or more factor: FBS > 126 mg/dl or waist > 102 cm for men and >
85 cm (for women) or TG > 150 mg/dl or HLD < 40 mg/dl for men and < 50 
mg/dl for women or systolic blood pressure > 130 mmHg and diastolic > 85 
mmHg.
2) Model 1: Adjusted for age and sex 
3) Model 2: Adjusted for age, sex and dietary intakes and physical activity
4) Model 3: Further adjusted for BMI 
5) FBS > 126 mg/dl or glucose 2 hpp > 200 mg/dl or using of hypoglycemic agents
6) Cholesterol > 240 mg/dl
7) LDL-C > 160 mg/dl
8) HDL-C > 40 mg/dl for men and > 50 mg/dl for women
9) TG > 200 mg/dl
10) Having one disorder in above lipid profiles
11) FBS > 126 mg/dl
Table 4. Multivariate adjusted odds ratio for cardiovascular risk factors by 
frequency of cheese consumption per week
factors of study participants by the frequency of cheese 
consumption. Higher consumption of cheese was associated 
with higher CRP, apolipoprotein A and HDL level but not with 
other cardiovascular risk factors including FBS, total cholesterol, 
LDL-C, TG and Apo B. Dietary intake of participants by frequency 
of cheese consumption are shown in Table 3. Higher consump-
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tion of cheese was positively associated with consumption of 
liquid and solid oil, grain, pulses, fruit, vegetable, meat and dairy 
products and negatively associated with Global Dietary Index. 
Crude and multivariate-adjusted odds ratio and 95% CI of 
cardiovascular risk factors in different groups of cheese intake 
are presented in Table 4. In crude model there was no difference 
between two groups but after adjustment for age and sex, low 
HDL level was negatively associated with cheese consumption 
(OR:0.89; 96% CI: 0.80-0.98). After control for other potential 
confounders such as dietary intakes and physical activity the 
association did not change. Further adjustment for BMI showed 
strong negative association between cheese intake with 
metabolic syndrome (OR:0.81; 96% CI: 0.71-0.94), low HDL level 
(OR:0.87; 96% CI: 0.79-0.96), and dyslipidemia (OR:0.88; 96%vCI: 
0.79-0.98).
DISCUSSION
In the present cross-sectional study as part of Isfahan Healthy 
Heart Program (IHHP), higher consumption of cheese was 
associated with lower cardiovascular and metabolic risk factors, 
which shows the beneficial effect of cheese intake. These results 
are apparently in contrast with previous knowledge about 
blood lipids and dietary fat consumption as cheese considered 
as a main source of saturated fat among dairy products. It has 
been reported that milk and dairy products consumption were 
positively correlated with total cholesterol, LDL-C and HDL-C 
levels [9]. In contrary, the consumption of milk and its products 
has been demonstrated to be negatively associated with the 
prevalence of metabolic syndrome [32]. These results are 
reported from various populations that consume different kinds 
of milk products, and this difference may be one possible reason 
for this inconsistency. For example, high consumption of milk 
in Scandinavian countries led to high mortality of heart disease 
whereas, high consumption of cheese in France may be one 
of the reasons of low heart disease mortality [33]. 
It is supposed that the effect of fat intake from cheese on 
serum lipids might be different from what expected from fat 
content. In a previous study a positive relationship was found 
between the intake of milk and heart disease mortality, although 
cheese consumption was negatively but not significantly 
correlated [25]. Another study showed a positive association 
between dairy fat intake and coronary heart diseases but the 
study recommended that cheese could be an exception [34]. 
Other studies also reported that individuals in higher category 
of cheese consumption were not at higher risk of myocardial 
infarction [28], hypertriglyceridemia [33] or high LDL-C level [35] 
than people consuming lower amount of cheese. It has been 
reported that cheese consumption could even reduce LDL-C 
in comparison with equal fat from butter [36].
Our finding that higher consumption of cheese can be 
inversely associated with cardiovascular risk factors including 
metabolic syndrome, low HDL-C level and hyperlipidemia is in 
accordance with other earlier investigations on cheese cons-
umption, which showed positive association between the intake 
of cheese and HDL-C level [24], and a negative association with 
total cholesterol levels [37] and metabolic syndrome [38,39]. 
Nevertheless, a prospective study found a positive association 
between cheese intake and cholesterol level, as well as IHD 
mortality [40]. Other studies reported a positive association 
between cheeses consumption and metabolic syndrome [41], 
cardiovascular risk factors [14] and myocardial infarction [27]. 
Different results among various studies might be depended on 
different population samples, lifestyles and study design [39].
A possible mechanism for beneficial effect of cheese cons-
umption could be the effect of the high content of calcium 
in cheese. Previous studies showed that dietary calcium with 
fat generate calcium soup and increase the excretion of lipid 
in feces [42] and significantly reduce serum cholesterol and 
triglyceride levels [43]. The effect of fermented dairy products 
on cholesterol concentration could be another mechanism for 
cheese effect. It has been suggested that the bacteria existed 
in large intestine convert unabsorbed carbohydrates to short- 
chain fatty acids, which could modify cholesterol synthesis in 
the liver. Also, these bacteria could bind bile acids to cholesterol 
and increase its excretion and reduce bile acid recycling [21]. 
Furthermore, high protein content of cheese, hypothesized as 
another possible mechanism for its effect on cholesterol [36].
Several limitations are considered in the current study. First, 
this study was designed as a cross-sectional study that makes 
decision on causality impossible. Second, to assess dietary 
intake we used qualitative FFQ that may lead to misclassification 
and underestimation and just give a crude estimate of the 
cheese intake, although it has been claimed that single FFQ 
ranks participants on total intake [44]. Third, there might be 
some residual confounding affecting the association between 
cheese consumption and cardiovascular risk factors, such as 
other lifestyle, dietary factors and dietary supplementation that 
were not controlled in our analysis. Finally we didn’t know about 
the fat content of consumed cheese. The fat content of cheese 
is an important factor influencing the result of different studies.
In conclusion, we found an inverse association between 
frequency of cheese intake and cardiovascular risk factors; 
however, further prospective studies are required to confirm 
the present results and to illustrate the probable mechanism.
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